BMY

#127
Bristol-Myers Squibb Co.
58.16 USD
+0.12%
セクター: ヘルスケア
ベース: USD
利益通貨: USD
日中レンジ
58.14
58.32
1年のレンジ
42.52
62.89
1日の変化
+0.12%
月次変化
-2.17%
6か月変化
+32.88%
1年の変化
+13.55%
以前の終値
58.09
始値
58.26
Bid
Ask
安値
58.14
High
58.32
ボリューム
1 284
チャート全体を表示

Financials

概要 明細書 統計 配当金
期次 年次
  • Market Capitalization 118.44 B
  • Employee 33 K
  • Founded N/A
  • CEO Chris Boerner
  • Website www.bms.com
  • Headquarter Delaware, United States
  • FIGI BBG000DQLV23
  • Industry Technology
総売上高
当期純利益
1株当たり基本利益（基本EPS）
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
15.59
売上高対価格比率
2.28
1株当たり配当金
2.49
配当利回り（％）
4.62

Bristol-Myers Squibb Company

Bristol-Myers Squibb Company, doing business as Bristol Myers Squibb, is an American multinational pharmaceutical company headquartered in Princeton, New Jersey. The company's primary products are apixaban for people with atrial fibrillation; nivolumab, used to treat certain types of cancer; lenalidomide, used to treat multiple myeloma, smoldering myeloma, and myelodysplastic syndromes; abatacept, used to treat autoimmune diseases such as rheumatoid arthritis; pomalidomide, an anti-cancer medication used for the treatment of multiple myeloma and AIDS-related Kaposi sarcoma; ipilimumab, to treat cancer; and luspatercept for the treatment of anemia in beta thalassemia and myelodysplastic syndromes. In 2024, 71% of the company's revenues came from the United States. The company is ranked 94th on the Fortune 500 and 173rd on the Forbes Global 2000.

ニュース